13.76
0.59 (4.48%)
| Penutupan Terdahulu | 13.17 |
| Buka | 13.36 |
| Jumlah Dagangan | 489,514 |
| Purata Dagangan (3B) | 687,466 |
| Modal Pasaran | 932,213,184 |
| Harga / Pendapatan (P/E TTM) | 33.56 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.78 |
| Harga / Jualan (P/S) | 1.60 |
| Harga / Buku (P/B) | 4.73 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2026 |
| Margin Keuntungan | -5.51% |
| Margin Operasi (TTM) | 4.01% |
| EPS Cair (TTM) | -0.480 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 197.40% |
| Nisbah Semasa (MRQ) | 1.43 |
| Aliran Tunai Operasi (OCF TTM) | 25.47 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 49.52 M |
| Pulangan Atas Aset (ROA TTM) | 3.33% |
| Pulangan Atas Ekuiti (ROE TTM) | -20.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Bioventus Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.50 |
|
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.87% |
| % Dimiliki oleh Institusi | 71.55% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |